Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome

References

• Sciuto M, Bertino G, Zocco M, et al. Incidence and causes of neonatal hyperbilirubinemia in a center of Catania. Therap Clin Risk Management 2009;5:247–50
   PubMedGoogle Scholar
• Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6–8
   PubMed Web of Science ®Google Scholar
• Academy of Pediatrics, Subcommittee on hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316
   PubMed Web of Science ®Google Scholar
• Maisles MJ, Kring E. Lenght of stay, jaundice and hospital readmission. Pediatrics 1998;101:995–8
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chen WC, Chen CM. Risk factor for hyperbilirubinemia in breastfed term neonates. Eur J Pediatr 2012;171:167–71
   PubMed Web of Science ®Google Scholar
• Shortland DB, Hussey M, Chowdhury AD. Understanding neonatal jaundice: UK practice and international profile. J R Soc Promot Health 2008;128:202–6
   PubMedGoogle Scholar
• Osborn LM, Bolus R. Breast feeding and jaundice in the first week of life. J Fam Pract 1985;20:475–81
   PubMed Web of Science ®Google Scholar
• Gourley GR, Arend RA. Beta-glucuronidase and hyperbilirubinaemia in breast-fed and formula-fed babies. Lancet 1986;1:644–6
   PubMed Web of Science ®Google Scholar
• Preer GL, Philipp BL. Understanding and managing breast milk jaundice. Arch Dis Child Fetal Neonatal Ed 2010;5:35–7
   Google Scholar
• Grunebaum E, Amir J, Merlob P, et al. Breast milk jaundice: natural history, familial incidence and later neurodevelopmental outcome of the infant. Eur J Pediatr 1991;150:267–9
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson L. Kernicterus in the 21st century: frequently asked questions. J Perinatol 2009;29:20–4
   PubMed Web of Science ®Google Scholar
• Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med 2001;344:581
   PubMed Web of Science ®Google Scholar
• Odell GB. Estrogenation of the newborn. In: Odell GB, ed. Neonatal hyperbilirubinaemia. New York: Grune and Stratton; 1980:39–41
   Google Scholar
• Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucoronosyltransferase 1 in Gilbert's syndrome. New Engl J Med 1995;333:1171–5
   PubMed Web of Science ®Google Scholar
• Monaghan G, McLellan A, McGeehan A, et al. Gilbert’s syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 1999;134:441–6
   PubMed Web of Science ®Google Scholar
• Kadakol A, Sappal BS, Ghosh SS, Lowenheim M. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinemia and may lead to neonatal kernicterus. J Med Genet 2001;38:244
   PubMed Web of Science ®Google Scholar
• Bancroft J, Kreamer B, Gourley R. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998;132:656–60
   PubMed Web of Science ®Google Scholar
• Watchko JF, Zhili L. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med 2010;15:169–75
   PubMed Web of Science ®Google Scholar
• Narter F, Can G, Isbir T, et al. Neonatal hyperbilirubinemia and G71R mutation of the UGT1A1 gene in Turkish patients. J Matern Fetal Neonatal Med 2010;8:324–7
   Google Scholar
• Babaoglu MO, Yigit S, Anacioglu AS, et al. Neonatal jaundice and bilirubin UDP-glucuronosyl transferase 1A1 gene polymorphism in Turkish patient. Basic Clin Pharmacol Toxicol 2006;98:377–80
   PubMed Web of Science ®Google Scholar
• Galanello R, Cipollina MD, Carboni G, et al. Hyperbilirubinemia, glucosa-6-phosphate dehydrogenase deficinecy and Gilbert’s syndrome. Eur J Pediatr 1999;158:914–6
   PubMed Web of Science ®Google Scholar
• Maruo Y, Nishizawa K, Sato H, et al. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyl transferase polymorphism. Pediatrics 1999;103:1224–7
   PubMed Web of Science ®Google Scholar
• Akaba K, Kimura T, Sasaki A, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate glucuronosyl transferase gene: a common mis-sense mutation among Japanese, Koreans and Chinese 1998;46:21–6
   Google Scholar
• Bosma P, Goldhorn B, Bakker C, et al. Presence of an additional TA in the TATA box of B-UGT1 correlates with Gilbert syndrome. Hepatology 1994;20:266A
   PubMed Web of Science ®Google Scholar
• Premawardhena A, Fisher CA, Liu YT, et al. The global distribution of length polymorphism of the promoters of the glucoronosyltransferase-1 gene (UGT1A1): hematologic and evolutionary implications. Blood Cells Mol Dis 2003;31:98–101
   PubMed Web of Science ®Google Scholar
• Ueyama H, Koiwai O, Soeda Y, et al. Analysis of the promoter of human bilirubin UDP-glucoronosyltransferase gene (UGT1A1) in relevance to Gilbert syndrome. Hepatol Res 1997;9:152–61
   Web of Science ®Google Scholar
• Clarke DJ, Moghrabi N, Monaghan G, et al. Genetic defects of the UDP-glucoronosyltransferase-1(UGT1) gene that cause familial non-hemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta 1997;266:63–74
   PubMed Web of Science ®Google Scholar
• Hsieh TY, Shiu TY, Huang SM, et al. Molecular pathogenesis of Gilbert syndrome: decreased TATA binding protein affinity of UGT1A1 gene. Pharmacogen Genom 2007;17:229–36
   PubMed Web of Science ®Google Scholar
• Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004;40:827–35
   PubMed Web of Science ®Google Scholar
• Jagarinec N, Flegar-Meštrić Z, Šurina B, et al. Pediatric reference interval for 34 biochemical analytes in urban school children and adolescents. Clin Chem Lab Med 1998;36:327-37
   PubMed Web of Science ®Google Scholar
• Kaplan M. Genetic interaction in the patogenesis of neonatal hyperbilirubinemia: Gilbert's syndrome and Glucose-6-phosphate dehydrogenase deficiency. J Perinat 2001;21:830–4
   Google Scholar
• Iolascon A, Faienza MF, Moretti A, et al. UGT1 promoter polymorphism accounts for increased neonatal appearence of hereditary spherocytosis. Blood 1998;98:1093
   Google Scholar
• Kaplan M, Renbaum P, Levi-Lahad E, et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose dependent genetic interaction crucial to neonatal hyperbilirubinaemia. Proc Natl Acad Sci 1997;94:128–32
   Web of Science ®Google Scholar
• Laforgia N, Faienza MF, Rinaldi A, et al. Neonatal hyperbilirubinemia and Gilbert's syndrome. J Perinat Med 2002;30:166–9
   PubMed Web of Science ®Google Scholar
• Carvahlo CG, Castro SM, Santin AP, et al. Polymorphic variants of UGT1A1 in neonatal jaundice in southern Brazil. J Trop Pediatr 2010;56:366–7
   PubMed Web of Science ®Google Scholar
• Sampietro M, Iolascon A. Molecular pathology of Crigler–Najjare type 1 and 2 and Gilbert's syndromes. Haematologica 1999;84:150–7
   PubMed Web of Science ®Google Scholar
• Roy-Chowdhury N, Deocharan B, Bejjanki HR, et al. Presence of the genetic marker for Gilbert syndrome is associated with increased level and duration of neonatal jaundice. Acta Paediatr 2002;91:100–1
   PubMed Web of Science ®Google Scholar
• Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 2002;7:135–41
   PubMedGoogle Scholar
• Bertini G, Dani C, Tronchini M, Rubaltelli F. Is breastfeeding really favoring early neonatal jaundice? Pediatrics 2001;107:E41
   PubMed Web of Science ®Google Scholar
• Watchko JF, Lin Z, Clark RH, et al. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 2009;124:868–77
   PubMed Web of Science ®Google Scholar
• Agrawal SK, Kumar P, Rathi R, et al. UGT1A1 gene polymorphism in North Indian neonates presenting with unconjugated hyperbilirubinemia. Pediatr Res 2009;65:67–80
   PubMed Web of Science ®Google Scholar
• Chou HC, Chen MH, Yang HI, et al. 211 GtoA variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice. Pediatr Res 2011;69:170–4
   PubMed Web of Science ®Google Scholar
• Muslu N, Turhan AB, Eskandri G, et al. The frequency of UDP-glucuronosyltransferase 1A1 promoter region (TA7) polymorphism in newborn and it's relation with jaundice. J Trop Paediatr 2007;53:64–8
   PubMed Web of Science ®Google Scholar
• Maruo Y, Nishizawa K, Sato H, et al. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the uridine diphosphate-glucuronosyltransferase gene. Pediatrics 2000;106:59–63
   PubMed Web of Science ®Google Scholar
• Chang PF, Lin YC, Liu K, et al. Prolonged unconjugated hyperbilirubinaemia in breast-fed male infants with a mutation of uridine diphosphate-glucuronosyl transferase. J Pediatr 2009;155:860–3
   PubMed Web of Science ®Google Scholar
• Žaja Franulović O. UDP-glucuronosyl transferase (UGT1A1) TATA box polymorphism in pediatric population and Gilbert's syndrome. J Pediatr Gastroenterol Nutr 2009;48:E134–5
   Google Scholar
• Ulgenalp AN, Duman N, Schaefer A, et al. Analyses of polymorphism for UGT1*1 exon 1 promoter in neonates with patologic and prolonged jaundice. Biol Neonate 2003;83:258–61
   PubMedGoogle Scholar
• Basiglio CL, Arriaga SM, Pelusa F, Almara AM. Complement activation and disease: protective effects of hyperbilirubinaemia. Clin Sci 2009;118:99–113
   Web of Science ®Google Scholar
• Madhavan N, Wattigney WA, Srinivasan SR, Berenson HS. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis 1997;131:107–13
   PubMed Web of Science ®Google Scholar
• Jangaa1rd KA, Fell DB, Dodds L, Allen AC. Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of ≥ 325 micromol/L (≥19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics 2008;122:119
   PubMed Web of Science ®Google Scholar
• Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 1994;54:477–81
   PubMed Web of Science ®Google Scholar
• Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ishemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449–56
   PubMed Web of Science ®Google Scholar
• McCarty MF. Iatrogenic Gilbert syndrome: a new strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin. Med Hypoth 2006;69:974–94
   Web of Science ®Google Scholar
• Lin JP, O Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels and coronary heart disease in the Framingham heart study. Circulation 2006;114:1476–81
   PubMed Web of Science ®Google Scholar